Brinker Capital Investments
EWTX icon

Brinker Capital Investments’s Edgewise Therapeutics EWTX Stock Holding History

Brinker Capital Investments’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$282K Buy
6,930
+481
+7% +$16.6K ﹤0.01% 1658
2026
Q1 		$203K Buy
+6,449
New +$186K ﹤0.01% 1862
2025
Q2 		– Sell
-11,633
Closed -$256K – 2001
2025
Q1 		$256K Sell
11,633
-295
-2% -$7.74K ﹤0.01% 1696
2024
Q4 		$318K Sell
11,928
-1,083
-8% -$34.5K ﹤0.01% 1532
2024
Q3 		$347K Buy
+13,011
New +$259K ﹤0.01% 1471

Other funds holding EWTX

OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Paradigm Biocapital Advisors
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Brinker Capital Investments's EWTX Position: Q2 2026 in Review

Brinker Capital Investments increased its Edgewise Therapeutics (EWTX) stake by 7.5% in Q2 2026, buying an estimated $16.6K and bringing the position to 6,930 shares worth $282K. The position accounts for ﹤0.01% of the portfolio, ranked #1658.

Brinker Capital Investments first reported a position in EWTX in Q3 2024 and has held it in 5 quarters since. The position peaked at $347K in Q3 2024. 226 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Brinker Capital Investments held 6,930 shares of Edgewise Therapeutics worth $282K as of Q2 2026.
  • Brinker Capital Investments bought 481 Edgewise Therapeutics shares in Q2 2026, an estimated $16.6K.
  • Edgewise Therapeutics made up ﹤0.01% of Brinker Capital Investments's portfolio in Q2 2026, its #1658 holding.
  • Brinker Capital Investments first reported a position in Edgewise Therapeutics in Q3 2024 and has held it in 5 quarters since.
  • Brinker Capital Investments's Edgewise Therapeutics position peaked at $347K in Q3 2024.
  • 226 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.